Seer - About the company
Seer is a public company based in San Francisco (United States), founded in 2017 by . It operates as a Developer of proteomics platform for early detection of cancer and neurological diseases. Seer has raised $128M in funding from investors like aMoon, Fidelity Investments and Wing Venture Capital. The company has 203 active competitors, including 60 funded and 31 that have exited. Its top competitors include companies like Metabolon, Cyrus Biotechnology and Maze Therapeutics.
Company Details
Developer of proteomics platform for early detection of cancer and neurological diseases. The company has developed a platform Proteograph which analyses the proteomics information and integrates it with genomics and other health data. Using this data it is developing liquid biopsy products for the early detection of cancer and neurological diseases.
- Website
- Social
- Email ID
- @seer.bio
- Phone Number
- +1
Key Metrics
Founded Year
2017
Location
San Francisco, United States
Stage
Public
Total Funding
in 7 rounds
Latest Funding Round
Investors
Ranked
6th among 203 active competitors
Annual Revenue
as on Dec 31, 2022
Employee Count
as on Dec 31, 2022
Similar Companies
Exit Details
Public
Legal entities associated with Seer
Seer is associated with 2 legal entities given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
|---|---|---|---|---|
$15.5M (as on Dec 31, 2022) | 647 | 142 | ||
Dec 31, 1999 | - | 638 | 958 |
Get your free copy of Seer's company profile
Seer's funding and investors
Seer has raised a total funding of $128M over 7 rounds. Its latest funding round was a Series D round on Jul 22, 2020 for $55M. 9 investors participated in its latest round, which includes T. Rowe Price, HBM Healthcare Investments, HTIF and Fidelity Investments.
Seer has 16 institutional investors including aMoon, Fidelity Investments and Wing Venture Capital.
Here is the list of recent funding rounds of Seer:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Jul 22, 2020 | $55M | Series D | 2952467 | 1924697 | |
Dec 17, 2019 | $55M | Series D | 9262273 | 2183420 | |
Sep 01, 2019 | $2.04M | Grant (prize money) | 9277595 | 8377310 |
Access funding benchmarks and valuations. Sign up today!View details of Seer's funding rounds and investors
Seer's founders and board of directors
View details of Seer's Founder profiles and Board Members
Seer's employee count trend
Seer has 89 employees as of Dec 22. The total employee count is the same as what it was in Dec 21. Here is Seer's employee count trend over the years:
Uncover Seer's growth story! Sign up today!Seer's Competitors and alternates
Top competitors of Seer include Metabolon, Cyrus Biotechnology and Maze Therapeutics. Here is the list of Top 10 competitors of Seer, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
|---|---|---|---|---|---|
1st | Metabolon 2000, Morrisville (United States), Series H | Provider of solutions for biomarker discovery, diagnostic tests and personalized medicine | $181M | EW Healthcare Partners, Perceptive AdvisorsÌý&²¹³¾±è;Ìý | 73/100 |
2nd | Cyrus Biotechnology 2014, Seattle (United States), Series B | Developer of cloud-based protein-modelling software for drug discovery | $32M | Orbimed, Trinity VenturesÌý&²¹³¾±è;Ìý | 71/100 |
3rd | Maze Therapeutics 2018, Redwood City (United States), Public | Developer of genetic bio-markers in neurological, metabolic, and renal diseases | $496M | Foresite Capital, Arch Venture PartnersÌý&²¹³¾±è;Ìý | 70/100 |
4th |  Vividion Therapeutics 2016, Oceanside (United States), Acquired | Developing novel drugs based on a proteome-wide ligand and target discovery platform | $271M | Versant Ventures, RA Capital ManagementÌý&²¹³¾±è;Ìý | 70/100 |
5th |  Alector 2013, San Francisco (United States), Public | Developing immuno-modulatory therapies for dementia and other neurodegenerative disorders | $215M | New Leaf Venture Partners, Foresite CapitalÌý&²¹³¾±è;Ìý | 70/100 |
6th | 2017, San Francisco (United States), Public | Developer of proteomics platform for early detection of cancer and neurological diseases | $128M | T. Rowe Price, HBM Healthcare InvestmentsÌý&²¹³¾±è;Ìý | 62/100 |
7th |  Tango Therapeutics 2017, Cambridge (United States), Public | Developer of drugs for the treatment of cancer | $165M | Third Rock Ventures, Casdin CapitalÌý&²¹³¾±è;Ìý | 66/100 |
8th | Biognosys 2008, Schlieren (Switzerland), Acquired | Provider of proteomics service | $9.13M | , BioMedPartnersÌý&²¹³¾±è;Ìý | 64/100 |
9th | NeoPhore 2017, Cambridge (United Kingdom), Series B | Developer of small molecule therapies to treat cancer | $44.6M | Astellas Venture Management, ParkwalkÌý&²¹³¾±è;Ìý | 63/100 |
10th | ProteinSimple 2004, San Jose (United States), Acquired | Provider tools to help researchers with protein analysis | $94.3M | Domain Associates, EW Healthcare PartnersÌý&²¹³¾±è;Ìý | 62/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Seer's competitors? Click to see the top ones
Seer's Investments and acquisitions
Seer has made no investments or acquisitions yet.
Reports related to Seer
Here is the latest report on Seer's sector:
View
News related to Seer
Media has covered Seer for a total of 7 events in the last 1 year, 3 of them have been about company updates and 1 about partnerships.
•
MarketBeat•Apr 28, 2025•Seer
•
GlobeNewswire•Feb 20, 2025•Seer
•
GlobeNewswire•Nov 22, 2024•Seer
•
GlobeNewswire•Nov 07, 2024•Seer,
•
•
GlobeNewswire•Jun 02, 2024•Seer
•
GlobeNewswire•May 09, 2024•Seer
•
GlobeNewswire•Mar 01, 2024•Seer
•
etfdailynews.com•Jan 22, 2024•Seer
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Frequently asked questions about Seer
When was Seer founded?
Seer was founded in 2017.Where is Seer located?
Seer is located in San Francisco, United States.When was the latest funding round of Seer?
Seer's latest funding round was on Jul 22, 2020.What is the annual revenue of Seer?
Annual revenue of Seer is $15.5M as on Dec 31, 2022.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Placement Officer - Unfunded company
- DAVS Solutions - Gurugram based, 2015 founded, Unfunded company
- Shaik Sabri - Unfunded company
- Karpos Rh - Lyon based, Unfunded company
- Comma Ads - United Arab Emirates based, Unfunded company
- Gazprom Space Systems - Moscow based, 1992 founded, Unfunded company
